Suppression of lymph node and lung metastases of endometrial cancer by muscle-mediated expression of soluble vascular endothelial growth factor receptor-3

Kayoko Takahashi; Hiroaki Mizukami; Yasushi Saga; Yuji Takei; Masashi Urabe; Akihiro Kume; Shizuo Machida; Hiroyuki Fujiwara; Mitsuaki Suzuki; Keiya Ozawa

doi:10.1111/cas.12184

Suppression of lymph node and lung metastases of endometrial cancer by muscle-mediated expression of soluble vascular endothelial growth factor receptor-3

Cancer Science ◽

10.1111/cas.12184 ◽

2013 ◽

Vol 104 (8) ◽

pp. 1107-1111 ◽

Cited By ~ 5

Author(s):

Kayoko Takahashi ◽

Hiroaki Mizukami ◽

Yasushi Saga ◽

Yuji Takei ◽

Masashi Urabe ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Endometrial Cancer ◽

Lymph Node ◽

Growth Factor ◽

Lung Metastases ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endothelial Growth Factor

Multi-Kinase Inhibitor E7080 Suppresses Lymph Node and Lung Metastases of Human Mammary Breast Tumor MDA-MB-231 via Inhibition of Vascular Endothelial Growth Factor-Receptor (VEGF-R) 2 and VEGF-R3 Kinase

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-07-5270 ◽

2008 ◽

Vol 14 (17) ◽

pp. 5459-5465 ◽

Cited By ~ 235

Author(s):

Junji Matsui ◽

Yasuhiro Funahashi ◽

Toshimitsu Uenaka ◽

Tatsuo Watanabe ◽

Akihiko Tsuruoka ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Lymph Node ◽

Growth Factor ◽

Breast Tumor ◽

Kinase Inhibitor ◽

Lung Metastases ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endothelial Growth Factor

Suppression of Tumor Lymphangiogenesis and Lymph Node Metastasis by Blocking Vascular Endothelial Growth Factor Receptor 3 Signaling

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/94.11.819 ◽

2002 ◽

Vol 94 (11) ◽

pp. 819-825 ◽

Cited By ~ 325

Author(s):

Y. He ◽

K.-i. Kozaki ◽

T. Karpanen ◽

K. Koshikawa ◽

S. Yla-Herttuala ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Lymph Node ◽

Growth Factor ◽

Lymph Node Metastasis ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Node Metastasis ◽

Tumor Lymphangiogenesis ◽

Endothelial Growth Factor

Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2011.07.006 ◽

2011 ◽

Vol 123 (2) ◽

pp. 393-400 ◽

Cited By ~ 22

Author(s):

Naz Chaudary ◽

Michael Milosevic ◽

Richard P. Hill

Keyword(s):

Vascular Endothelial Growth Factor ◽

Lymph Node ◽

Growth Factor ◽

Lymph Node Metastases ◽

Growth Factor Receptor ◽

Cervix Cancer ◽

Vascular Endothelial ◽

Node Metastases ◽

Factor C ◽

Endothelial Growth Factor

Vascular endothelial growth factor receptor 1 expression in breast carcinoma is a predictor of sentinel lymph node micrometastatic disease

Irish Journal of Medical Science (1971 -) ◽

10.1007/bf03170026 ◽

2002 ◽

Vol 171 (S2) ◽

pp. 14-14

Author(s):

M. A. Kelly ◽

J. Murphy ◽

K. C. Redmond ◽

H. P. Redmond

Keyword(s):

Vascular Endothelial Growth Factor ◽

Lymph Node ◽

Growth Factor ◽

Sentinel Lymph Node ◽

Breast Carcinoma ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Micrometastatic Disease ◽

Endothelial Growth Factor

Induction of lymphangiogenesis through vascular endothelial growth factor-C/vascular endothelial growth factor receptor 3 axis and its correlation with lymph node metastasis in nasopharyngeal carcinoma

Oral Oncology ◽

10.1016/j.oraloncology.2012.02.003 ◽

2012 ◽

Vol 48 (8) ◽

pp. 703-708 ◽

Cited By ~ 18

Author(s):

Naohiro Wakisaka ◽

Kyoko Hirota ◽

Satoru Kondo ◽

Seiko Sawada-Kitamura ◽

Kazuhira Endo ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Lymph Node ◽

Growth Factor ◽

Nasopharyngeal Carcinoma ◽

Lymph Node Metastasis ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Node Metastasis ◽

Factor C ◽

Endothelial Growth Factor

The Effect of Combination Anti–Endothelial Growth Factor Receptor and Anti–Vascular Endothelial Growth Factor Receptor 2 Targeted Therapy on Lymph Node Metastasis

Archives of Otolaryngology - Head and Neck Surgery ◽

10.1001/archoto.2009.14 ◽

2009 ◽

Vol 135 (4) ◽

pp. 411 ◽

Cited By ~ 18

Author(s):

Daisuke Sano ◽

Sungweon Choi ◽

Zvonimir Luka Milas ◽

Ge Zhou ◽

Chad E. Galer ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Lymph Node ◽

Targeted Therapy ◽

Growth Factor ◽

Lymph Node Metastasis ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Node Metastasis ◽

Endothelial Growth Factor

974. Adeno-Associated Viral (AAV)-Mediated Gene Transfer of Soluble Vascular Endothelial Growth Factor Receptor 3 (sVEGFR3) Inhibits Development of Lymph Node Metastases

Molecular Therapy ◽

10.1016/j.ymthe.2004.06.917 ◽

2004 ◽

Vol 9 ◽

pp. S373

Keyword(s):

Vascular Endothelial Growth Factor ◽

Lymph Node ◽

Growth Factor ◽

Gene Transfer ◽

Lymph Node Metastases ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Node Metastases ◽

Endothelial Growth Factor

Fortgeschrittenes medulläres Schilddrüsenkarzinom: Vandetanib verbessert das progressionsfreie Überleben

Onkologische Welt ◽

10.1055/s-0038-1631032 ◽

2012 ◽

Vol 03 (02) ◽

pp. 93-92

Author(s):

Alexander Kretzschmar

Keyword(s):

Vascular Endothelial Growth Factor ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Phase Iii ◽

Vascular Endothelial ◽

Medulläres Schilddrüsenkarzinom ◽

Epidermal Growth ◽

Endothelial Growth Factor

Vandetanib ist ein oraler Hemmer des RET-Kinase-, VEGF (Vascular Endothelial Growth Factor Receptor)- und EGFR (Epidermal Growth Factor Receptor)-Signalwegs. In einer zulassungsrelevanten, randomisierten, doppelblinden, placebokontrollierten Phase- III-Studie verlängerte der Tyrosinkinasehemmer das progressionsfreie Überleben (PFS) signifikant länger als Placebo.

Expression des „Epidermal Growth-Factor Receptor“ (EGFR) und des „Vascular Endothelial Growth Factor“ (VEGF) bei Lymphangioleiomyomatose (LAM)

Pneumologie ◽

10.1055/s-2006-934022 ◽

2006 ◽

Vol 60 (S 1) ◽

Author(s):

H Watz ◽

K Engels ◽

M Amthor ◽

D Kirsten ◽

H Magnussen

Keyword(s):

Vascular Endothelial Growth Factor ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Epidermal Growth ◽

Endothelial Growth Factor

Faculty Opinions recommendation of Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1163678.625451 ◽

2009 ◽

Author(s):

David Bates

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Lymphatic Vessel ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endogenous Inhibitor ◽

Vessel Growth ◽

Alternatively Spliced ◽

Endothelial Growth Factor